Coverage dated October 29, 2026 to November 1, 2026
Bayer wins Roundup cancer trial
Headline from Bismarck Tribune
NEW YORK — Bayer won a trial on Thursday over claims by three women that its Roundup weed killer caused their cancer, while awaiting a broader ruling from a separate court on the company's $7.25 billion effort to settle other…
Bismarck Tribune's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
A jury in St. Louis rejected claims by three women who blamed Bayer AG’s Roundup weedkiller for their cancers, bolstering the company’s effort to contain the cost of tens of thousands of similar lawsuits in the US that it has offered to settle.
The weedkiller Roundup has been accused of being carcinogenic to humans despite no warning on its label. Bayer is seeking to settle tens of thousands of further cases.
NEW YORK — Bayer won a trial on Thursday over claims by three women that its Roundup weed killer caused their cancer, while awaiting a broader ruling from a separate court on the company's $7.25 billion effort to settle other…
NEW YORK — Bayer won a trial on Thursday over claims by three women that its Roundup weed killer caused their cancer, while awaiting a broader ruling from a separate court on the company's $7.25 billion effort to settle other…
